Study shows mortality benefit with ASV

05.07.2021

A recent study from Hawaii showed significantly lower percent mortality with Adaptive Support Ventilation (ASV®).

The retrospective, observational study compared a group of 684 general ICU patients treated with conventional, non-automated ventilation to a second group of 196 patients managed with automated ventilation (ASV). Although there was no significant difference in the duration of ventilation, percent mortality on the ventilator was significantly lower in the ASV group (8.6% vs. 27.3%).

During the discussion, the authors touched on the benefits for clinical staff, noting that there were fewer nuisance alarms and the physicians were called less often for changes related to tidal volume and respiratory rate. They also stated that the closed-loop ventilation process seemed to perform well on the whole spectrum of patients, even those complex ones with multi-system failure ARDS.

Access publication

Sanderson RR, Whitley D, Batacan C. Automated mechanical ventilation using Adaptive Support Ventilation versus conventional ventilation including ventilator length-of-stay, mortality, and professional social aspects of adoption of new technology. J Mech Vent 2020; 2(2):48-52.

Date of Printing: 06.08.2021
Disclaimer:
The content of this article is for informational purposes only and is not intended to be a substitute for professional training or for standard treatment guidelines in your facility. Any recommendations made in this article with respect to clinical practice or the use of specific products, technology or therapies represent the personal opinion of the author only, and may not be considered as official recommendations made by Hamilton Medical AG. Hamilton Medical AG provides no warranty with respect to the information contained in this article and reliance on any part of this information is solely at your own risk.